Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

6,112

Participants

Timeline

Start Date

September 7, 2020

Primary Completion Date

July 8, 2021

Study Completion Date

July 8, 2021

Conditions
Respiratory Tract InfectionsCovid19
Interventions
DRUG

Bacille Calmette-Guérin (BCG)

Participants in the intervention group will be vaccinated with the licensed BCG vaccine (Danish strain 1331, SSI, Denmark) using the standard vaccination technique for this vaccine (intradermal injection in the left upper arm).

DRUG

Placebo

Intradermal injection of sterile 0.9% NaCl.

Trial Locations (20)

Unknown

Meander Medical Center, Amersfoort

Amsterdam University Medical Center, Amsterdam

OLVG, Amsterdam

Rijnstate hospital, Arnhem

Amphia hospital, Breda

Catharina hospital, Eindhoven

Zuyderland Hospital, Geleen

Martini hospital, Groningen

University Medical Center Groningen, Groningen

Leiden University Medical Center, Leiden

Maastricht University Medical Center, Maastricht

St. Antonius hospital, Nieuwegein

Canisius-Wilhelmina Hospital, Nijmegen

Radboud University Medical Center, Nijmegen

Erasmus Medical Center, Rotterdam

Ikazia Hospital, Rotterdam

Maasstad Hospital, Rotterdam

Hagahospital, The Hague

Bernhoven hospital, Uden

University Medical Center Utrecht, Utrecht

All Listed Sponsors
lead

UMC Utrecht

OTHER

NCT04537663 - Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults | Biotech Hunter | Biotech Hunter